Blog
Pharmacovigilance conferences are a flea market
If you ever attended a pharmacovigilance conference, you may have thought the same: “What on earth is this? Isn’t pharmacovigilance meant to help protect patients from ineffective or even dangerous medicines, playing a potentially crucial part in society?”
Interpreting fuzzy regulations: What literature should I monitor and how often?
We all know that literature screening is required to meet pharmacovigilance obligations. Everyone is doing it. But actually: Is the requirement to monitor literature clear after all?
You could start using a new safety database today
How to recognize a truly modern pharmacovigilance database for your company? Implementation speed is an indicator that says a lot. Let us explain what’s possible.
Unlimited Users and Cases Make a Huge Difference
What does it mean in practice if you don’t have to pay for users and cases in your safety database? Explore all the side effects of a truly flexible, unlimited pricing of pharmacovigilance software.
Let’s have a chat
Whatever you needs are, we look forward to getting in touch with you.
Feel free to drop us a message and we will contact you right away.
Tepsivo Oy | Haartmaninkatu 4, Building 14, 00290, Helsinki, Finland | VAT number FI31367614 | contact@tepsivo.com | +358 402 204 698 | Privacy policy



